On the one-year anniversary of the U.N. High-Level Meeting on Non-Communicable Diseases (NCDs), two blogs examine what has happened since. In the Center for Global Development’s (CGD) “Global Health Policy” blog, Victoria Fan, a research fellow at the center, and Laura Khan of Princeton University ask, “[W]here has the attention and commitment to NCDs gone?” They say “subsequent attention and action after the NCD Summit last year has been paltry,” and they explore some reasons why this might be the case (9/19). In an interview on the Council on Foreign Relations blog, Thomas Bollyky, senior fellow for global health, economics, and development, says, “So on one hand, the U.N. NCD meeting hasn’t yet managed to follow the HIV/AIDS blueprint in producing a groundswell of popular support, new donor resources, and concrete country action. On the other hand, optimists on this issue believe the U.N. meeting elevated a long-neglected cause to the heads-of-state level and firmly established it as an ongoing concern for the U.N.” (Johnson, 9/19).
Non Communicable Disease/Chronic Disease
Noting this week marks the first anniversary of the U.N. High-Level Meeting on Non-Communicable Diseases (NCDs), a Lancet editorial states, “The meeting was a crucial step for putting diseases such as cancer and cardiovascular disease high on the global health agenda. However, little action, other than more talking, has been taken since.” The editorial continues, “The key positive development of the past year was the goal to reduce preventable deaths from NCDs by 25 percent by 2025 passed by the World Health Assembly in May,” but “[t]he challenge now is how to meet it.”
“If left unaddressed, [non-communicable diseases (NCDs)] will lead to more death, disability and the implosion of already overburdened health systems in developing countries at huge cost to individuals, families, businesses and society,” Peter Piot, director of the London School of Hygiene and Tropical Medicine and former UNAIDS executive director, writes in the Huffington Post “Impact” blog, adding, “Like AIDS, NCDs are a problem for rich and poor countries alike, but the poor suffer the most.” He continues, “The 2011 U.N. High-Level Meeting on NCDs — only the second time the U.N. had convened a major meeting on a health issue, following the U.N. AIDS Summit in June 2001 — was a landmark event in the short history of the fight against NCDs but was not a tipping point. Much more remains to be done.”
“Cancers, cardiovascular diseases, chronic lung diseases and diabetes — four of the biggest killers among the group together known as non-communicable diseases (NCDs) — have emerged as one of the greatest social and economic development challenges of this century,” George Alleyne, director emeritus of PAHO, and Nils Daulaire, director of the Office of Global Affairs at the Department of Health & Human Services and the U.S. representative on the WHO’s Executive Board, write in the Huffington Post’s “Impact” blog. “On the first anniversary of the United Nations High-Level Meeting on NCDs where the world formally acknowledged the urgent need for action on these under-recognized diseases, it makes sense to assess how far we’ve come, as well as how much further we need to go,” they continue, adding, “During the past 12 months, health workers, policymakers and activists rallied around the High-Level Meeting to build a robust civil society movement, which has continued to gather momentum.”
In this post in the Guardian’s “Poverty Matters” blog, Johanna Ralston, chief executive of the World Heart Federation, and Ann Keeling, chief executive of the International Diabetes Federation, argue non-communicable diseases (NCDs) must be part of any new global development goals, writing, “NCDs and their risk factors worsen poverty, while poverty contributes to rising rates of NCDs, posing a threat to sustainable development.” They continue, “In 2000, world leaders drafting the millennium development goals (MDGs) addressed many of the great development challenges, but they made one serious mistake: they omitted any mention of NCDs, which together cause nearly two out of three deaths in the world (80 percent of those in developing countries).”
“A new way to screen poor women for cervical cancer was introduced this month in El Salvador, using a test that was originally developed in China,” the New York Times reports. “The new test, called careHPV and made by Qiagen, a Dutch company, is a swab test for the DNA of the papillomaviruses that cause cancer,” the newspaper writes, noting a study published in the Lancet Oncology in 2008 found the test “was more than twice as sensitive” than the alternate method of “shining a light on the cervix and painting it with vinegar, which reveals precancerous lesions that can then be burned off with liquid nitrogen or carbon dioxide.” According to the New York Times, “The test worked even when women inserted the swabs themselves, which can be done at home and so is easier and faster than having them go to a clinic for visual inspections” (McNeil, 9/24).
“Some academics and non-profit organizations are skeptical of the motives of the increasing number of multinational companies who seek partnerships to address non-communicable diseases (NCDs),” Derek Yach, senior vice president of global health and agriculture policy at PepsiCo and former head of NCDs at WHO, writes in the Huffington Post’s “Impact” blog. He asks, “So how well is the private sector doing in tackling the rising pandemic of NCDs, which cause nearly two out of every three deaths in the world (80 percent of those in developing countries), the four main ones being cancer, cardiovascular disease, chronic respiratory disease and diabetes?” He continues, “The private sector is a major stakeholder in many ways — as employers; makers of food and medicines, sports gear and technology; as corporate citizens and consumers — and wants to be engaged in the global NCD dialogue. We deserve a seat at the table.”
“About 200 million people around the world use illegal drugs every year, and that may be taking a toll on health and death rates in various countries, says a report released Thursday in the Lancet,” the Los Angeles Times’ “Booster Shots” blog reports. According to the blog, “[t]he study, part of a series the journal is doing on addiction, offers a plethora of information about [the] use of opioids, amphetamines, cocaine and marijuana worldwide” (Stein, 1/5).
“In 2012 there will be a major strategic shift in global health, away from development and towards sustainability,” a Lancet editorial states. “Since 2000, the Millennium Development Goals (MDGs), driven by a macroeconomic diagnosis of global poverty, have focused on investment in a small number of diseases as the most effective approach to decrease poverty, … [b]ut this approach is now delivering diminishing returns,” because of emerging challenges such as non-communicable diseases (NCDs), climate change, and financial security, as well as a heightened focus on integration and accountability, the editorial says.
“Countries need to change their current mindset to successfully tackle non-communicable diseases (NCDs), the head of the United Nations World Health Organization (WHO) said [Monday], adding that governments will need to explore new approaches to prevent and treat these diseases, which have quickly become one of the most pressing issues in public health,” the U.N. News Centre reports (1/16). “In an opening speech to the annual WHO Executive Board meeting, Director-General Margaret Chan … urged the 34-member board to tackle the root causes of non-communicable diseases,” VOA News writes (Schlein, 1/16).